NCT00556114

Brief Summary

Growing evidence shows that altered blood flow plays a major role in many vision-threatening diseases including glaucoma, diabetic retinopathy, age-related macular degeneration, Central Retinal Vein Occlusion, and Branch Retinal Vein Occlusion. Optical coherence tomography, an established imaging technique use for eye exam in clinical ophthalmology, provides high-resolution cross sectional images of the retina and has increased our ability to understand many eye diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 7, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 9, 2007

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

October 20, 2022

Status Verified

October 1, 2022

Enrollment Period

6.5 years

First QC Date

November 7, 2007

Last Update Submit

October 19, 2022

Conditions

Keywords

eye examRetina

Outcome Measures

Primary Outcomes (1)

  • Medical exam tool

    Optical Coherence Tomography imaging technique of the retina and ability to diagnose and manage many eye diseases

    24 hours

Study Arms (1)

Optical Coherence Tomography

Optical Coherence Tomography

Device: Optical Coherence Tomography

Interventions

Optical Coherence Tomography

Optical Coherence Tomography

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Primary care clinic and community sample.

You may qualify if:

  • Adult 18 years and older with normal eye, or has been diagnosed with eye disease.

You may not qualify if:

  • Less than 18 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beckman Laser Institute, University of California,Irvine

Irvine, California, 02612, United States

Location

MeSH Terms

Conditions

GlaucomaDiabetic RetinopathyMacular DegenerationRetinal Vein Occlusion

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Ocular HypertensionEye DiseasesRetinal DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesRetinal DegenerationVenous ThrombosisThrombosisEmbolism and Thrombosis

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Baruch D Kuppermann,, M.D., Ph.D.

    Ophthamology, University of California,Irvine

    PRINCIPAL INVESTIGATOR
  • Zhongping Chen, Ph,D

    Beckman Laser Institute University of California Irvine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Baruch D. Kuppermann, M.D., Ph.D.,Professor Department of Ophthalmology and Biomedical Engineering

Study Record Dates

First Submitted

November 7, 2007

First Posted

November 9, 2007

Study Start

January 1, 2007

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

October 20, 2022

Record last verified: 2022-10

Locations